Clinical Trials Logo

Methamphetamine Dependence clinical trials

View clinical trials related to Methamphetamine Dependence.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT01601717 Withdrawn - Substance Abuse Clinical Trials

RTI-336 as a Treatment for Methamphetamine Dependence

Start date: January 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of RTI-336 as a treatment for methamphetamine (METH) dependence in non-treatment-seeking METH-dependent volunteers.

NCT ID: NCT00733967 Withdrawn - Substance Abuse Clinical Trials

Varenicline-Methamphetamine Interaction Study (2008)

Start date: January 2008
Phase: Phase 1
Study type: Interventional

The primary aim of the study is to determine the safety and tolerability of treatment with Varenicline in methamphetamine-dependent volunteers. The investigators also seek to determine the effects of treatment with Varenicline, as compared to placebo, on craving for methamphetamine or cigarettes following exposure to methamphetamine and smoking cues, respectively. The effects of treatment with Varenicline, as compared to placebo, on subjective effects produced by administration of methamphetamine or placebo will be attempted to be determined. Lastly, the investigators hope to determine the effects of treatment with Varenicline, as compared to placebo, on reinforcing effects produced by administration of methamphetamine or placebo.

NCT ID: NCT00728312 Withdrawn - Clinical trials for Methamphetamine Dependence

Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial

Start date: August 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to test whether treatment with Aripiprazole leads to a reduction in methamphetamine craving and use in patients diagnosed with methamphetamine dependence. Patients presenting at the Omaha VA Medical Center for treatment of methamphetamine dependence, and meet inclusion criteria for the study will be invited to participate. Participation in the study will last for approximately 14 weeks.